In the context of the relevance of N-Cadherin to invasion and metastasis of carcinoma cells and downregulation of E-Cadherin in malignant cells compared to normal cells28, 29, it makes sense that TrxR1 inhibition by BBSKE may bring about reversion of some dysplastic phenotypes. The gene discussed is CDH1; the disease is carcinoma.